Emerging Strategies in Prostate Cancer: Molecular Glues and T-Cell Engagers | CancerNetwork Benjamin Garmezy, MD, discussed the potential of a GSPT1 molecular glue degrader and a trispecific T-cell engager in treating select prostate cancers.

🧬 Dr. Benjamin Garmezy discusses emerging prostate cancer strategies—highlighting molecular glues & T‑cell engagers—in a new CancerNetwork interview.
🔗 www.cancernetwork.com/view/emergin...
#ProstateCancer #Oncology #PrecisionMedicine #SCRI

Atebimetinib Signals a Potential Shift in First-Line Pancreatic Cancer Outcomes | Pharmacy Times Experts discuss groundbreaking data on pancreatic cancer treatment, revealing a 64% survival rate and its potential to transform patient care and outcomes.

SCRI and SCRI Oncology expert, Dr. Meredith Pelster joined Pharmacy Times to discuss emerging data that could meaningfully change the treatment landscape for pancreatic cancer. Watch below to learn more:
www.pharmacytimes.com/view/atebime...
#PancreaticCancer #SCRI #OncologyResearch

This week! And we can't wait! Thursday at 4:00. Right here #SCRI in beautiful #ygk. #gerionc #cancer #aging

Erika Hamilton: SCRI Oncology Partners Welcome Tennessee State Legislators - OncoDaily Erika Hamilton: SCRI Oncology Partners Welcome Tennessee State Legislators / cancer, Erika Hamilton, OncoDaily, Oncology, SCRI Oncology Partners

SCRI Oncology Partners Welcome Tennessee State Legislators - Erika Hamilton

@erikahamilton9.bsky.social @scri.com

oncodaily.com/voices/erika...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SCRI

⚡️ #Moderna débute une étude pour le traitement d'un #MyélomeMultiple 🩸

La première dose a été administrée au #SCRI Oncology Partners à #Nashville, dans le #Tennessee, en collaboration avec le Sarah Cannon Research Institute (SCRI).
www.tradingsat.com/moderna-US60...

Client Challenge Please enable JavaScript to proceed.

MorningSun trial shows SC mosunetuzumab is effective & well-tolerated for elderly or CIT-ineligible #DLBCL patients. Featuring SCRI’s Dr. Jeff Sharman:
www.hmpgloballearningnetwork.com/site/onc/new... #ASH25 #InnovationInOncology #SCRI

Congrats to our SCRI team for powering 100 abstracts & 50+ investigator-led presentations across hematologic diseases.
Patients remain at the center of all we do—here’s to driving impact beyond Orlando!
#SCRI

Meet #SCRI experts at #ASH25. Visit booth 1580 and view our full schedule: uberflip.scri.com/i/1541695-me...?

Hematology is evolving fast, and SCRI experts are leading the way. Ahead of #ASH25, explore 5 trends shaping research and collaboration this year.
Read more: www.scri.com/news/sarah-c...
#SCRI #ASH25 #Hematology #Oncology

The nerve to fight cancer | Queen's Gazette Associate professor Sebastien Talbot is paving the way for new cancer therapies through the nerve–immune connection

Dr. Sébastien Talbot, a member of #SCRI, explores how the nervous system might have an important role in treating tumors. Read all about how Dr. Talbot is advancing the field of cancer neuroscience ⬇️ @queensuhealth.bsky.social @queensuresearch.bsky.social
www.queensu.ca/gazette/stor...

Can a molecular assay call you high risk in #lungcancer ? #DrDavidSpigel is looking to figure that out #RazorGenomics youtu.be/loZ4Zpgy9gI @ascocancer.bsky.social #SCRI #P2PMD #ShortTakesInOncology

Stage 1 Testicular Cancer: A Patient Education Overview | CURE From diagnosis to treatment, here is what patients need to know about stage 1 testicular cancer.

SCRI expert Dr. Ben Garmezy shares insights on testicular cancer diagnosis, treatment choices, and patient education in this CURE Today feature.
Read more:
www.curetoday.com/view/stage-1...
#CancerEducation #TesticularCancer #SCRI

We're excited to announce the next speaker in our #SCRI seminar series! Dr. Vuk Stambolic will be presenting here
@sinclaircri.bsky.social in #YGK on Oct 30th. Everyone is welcome! @pmresearch-uhn.bsky.social @queensuhealth.bsky.social @queensuresearch.bsky.social #breastcancer

Your breast cancer risk is personal—and understanding it is powerful.
SCRI's Dr. Denise Yardley shares how genetic testing is changing prevention on @newschannel5plus.bsky.social .
🎥 Watch: bit.ly/DrYardleyBCAM
#BCAM #BreastCancerAwareness #EarlyDetection #SCRI

Honoring President and Chief Medical Officer, Dr. Howard “Skip” Burris - Sarah Cannon Research Institute - OncoDaily Honoring President and Chief Medical Officer, Dr. Howard “Skip” Burris - Sarah Cannon Research Institute / cancer, David R. Spigel, Erika Hamilton, Headlines,

Sarah Cannon Research Institute - Honoring President and Chief Medical Officer, Dr. Howard “Skip” Burris

@scri.com

oncodaily.com/career/chief...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SCRI

At 45, Bryan was diagnosed with advanced prostate cancer.
A BRCA mutation led him to a clinical trial through SCRI at Texas Oncology.
Today, his PSA levels are undetectable—and he’s thriving. 💙
#ProstateCancer #BRCA #SCRI #TexasOncology #USOncologyNetwork #ClinicalTrials #CancerResearch

Bill, 76, joined a clinical trial at SCRI to treat stage IV prostate cancer. His goal: dance at his daughter’s wedding. ✅
Now celebrating a grandchild & still practicing law—while seeing a 15% reduction in disease.
Hope lives here.
🔗 www.scri.com/patients/?co...
#SCRI #ClinicalTrials #ProstateCancer

Episode 12: Variant Histology Treatment Considerations From World GU 2025 | CancerNetwork Experts highlight methods for optimally treating patients with genitourinary cancers harboring variant histologies at World GU 2025.

🎧 SCRI’s Dr. Garmezy & Dr. Bupathi share expert insights on treating variant histologies in GU cancers at #WorldGU2025 on Oncology Decoded.
🔗 www.cancernetwork.com/view/episode...
#SCRI #CancerResearch #GUOncology #OncologyDecoded

Mary is proof that hope and research go hand in hand.
She’s in a clinical trial for IV #ovariancancer at #SCRI at Mary Crowley—and her disease has remained stable since March.
She’s walked the Camino de Santiago, joined the Lourdes Pilgrimage, & got a tattoo to celebrate it all. #PatientStories

Dr. Hans Lee & Dr. Kris Patel from SCRI Oncology share how new therapies like CAR T-cell treatment are changing lives.

📺 Watch the News Channel 5 segment: www.youtube.com/watch?v=hg4_...
#BloodCancerAwareness #LymphomaAwareness #CancerCare #SCRI

#SCRI at #TerryFoxRun. Cancer research at Queen’s is out to run!

Early data for new pancreatic cancer vaccine generating hope among patients, researchers Early data for a new vaccine for pancreatic cancer is generating some hope among patients and researchers.

Dr. Jason Henry featured on @DenverChannel discussing early data from a promising #pancreaticcancer vaccine.
“This is one of the most exciting times in pancreatic cancer research in the last 100 years.”
#SCRI #CancerResearch #ClinicalTrials
www.denver7.com/lifestyle/he...

youtube.com/watch?v=PkXEvgjh37Y

Nice presentation by #DrBenGarmezy @ascocancer.bsky.social of his poster! Work still continues to unlock #cancer in solid tumors. #SCRI #Exelixis #shorttakesinoncology

JP was diagnosed with stage IV lung cancer. He joined a clinical trial through SCRII at OHC—and responded to immunotherapy.

Now in remission, he celebrates each year with a cake and a message of hope. 🎂

#SCRI #CancerSurvivor #Immunotherapy #ClinicalResearch

www.scri.com/patients/?co...

Highlighting Breast Cancer Advances at IBC East Leading experts in the breast cancer field highlight the use of CDK4/6 inhibitors, antibody-drug conjugates, and other treatment modalities.

New from #CancerNetwork: Dr. Erika Hamilton of SCRI Oncology Partners shares insights on ADCs, CDK4/6 inhibitors & early breast cancer care from #IBC25.
🎧 Listen: www.cancernetwork.com/view/highlig...

#BreastCancer #Oncology #SCRI

💡 Why consider a clinical trial during your cancer journey?
✨ Access cutting-edge treatments
✨ Stay close to home
✨ Help shape the future of cancer care
🎥 Watch our latest video to learn more: www.scri.com/patients/
#CancerAwareness #ClinicalTrials #OncologyResearch #SCRI #HopeCloseToHome

Thank you, #ASCO25!

We’re grateful to our presenters, panelists, and the entire ASCO community for an inspiring week of innovation and collaboration.

Here’s to advancing therapies for patients —together.
Until next year!
#SCRI #CancerResearch #OncologyLeadership #ThankYouASCO

🚨 LIVE from #ASCO25 🚨
Dr. Erika Hamilton presents first-in-human data on Emi-Le (B7-H4 ADC) in solid tumors.

🔹 ORR: 31% in B7-H4 high
🔹 ORR: 44% w/ ≤4 prior lines
🔹 ACC-I: 55.6% ORR

Promising activity + tolerability in mBC, OC, EC & ACC-I.
#SCRI #ADC #Oncology #ASCO2025

Dr. Johnson tackled how community oncology can deliver cutting-edge lung cancer therapies:

🔹 Not all bispecifics need inpatient care
🔹 Tarlatamab = outpatient-friendly
🔹 Innovative care models = better access

#LungCancer #Immunotherapy #SCRI #ASCO25